Vyome Holdings (HIND) Non-Current Debt (2015 - 2021)
Vyome Holdings (HIND) posted quarterly Non-Current Debt of $3.0 million for Q3 2021, up 597.67% year-over-year from $430000.0 in Q3 2020, and up 2.18% quarter-over-quarter from $2.9 million in Q2 2021.
Vyome Holdings (HIND) Non-Current Debt (2015 - 2021) Analysis & Trends
Vyome Holdings' Non-Current Debt history runs 7 years deep, the most recent figure standing at $3.0 million for Q3 2021.
- In Q3 2021, Non-Current Debt rose 597.67% year-over-year to $3.0 million; the TTM figure through Sep 2021 stood at $3.0 million (up 597.67% YoY), while the FY2020 annual figure was $9.2 million, changed N/A from the prior year.
- Non-Current Debt for Q3 2021 stood at $3.0 million, up from $2.9 million in the prior quarter.
- The five-year high for Non-Current Debt was $20.0 million in Q1 2019, with the low at $430000.0 in Q2 2020.
- The 5-year median for Non-Current Debt is $9.0 million (2017), against an average of $7.6 million.
- The sharpest annual moves came in 2020 and 2021: Non-Current Debt slumped 91.4% in 2020, then jumped 597.67% in 2021.
- Vyome Holdings' Non-Current Debt stood at $8.0 million in 2017, then climbed by 24.69% to $9.9 million in 2018, then slumped by 49.65% to $5.0 million in 2019, then jumped by 83.36% to $9.2 million in 2020, then sank by 67.28% to $3.0 million in 2021.
- Business Quant data shows HIND's Non-Current Debt at $3.0 million in Q3 2021, $2.9 million in Q2 2021, and $9.2 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 8.96 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.97 Mn |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 3.00 Mn |
| Jun 30, 2021 | 2.94 Mn |
| Dec 31, 2020 | 9.17 Mn |
| Sep 30, 2020 | 430,000.00 |
| Jun 30, 2020 | 430,000.00 |
| Jun 30, 2019 | 5.00 Mn |
| Mar 31, 2019 | 19.95 Mn |
| Dec 31, 2018 | 9.93 Mn |
| Sep 30, 2018 | 9.92 Mn |
| Jun 30, 2018 | 9.95 Mn |
| Mar 31, 2018 | 6.97 Mn |
| Dec 31, 2017 | 7.96 Mn |
| Sep 30, 2017 | 8.96 Mn |
| Jun 30, 2017 | 9.90 Mn |
| Mar 31, 2017 | 9.89 Mn |
| Dec 31, 2016 | 9.88 Mn |
| Sep 30, 2016 | 9.89 Mn |
| Dec 31, 2015 | 9.09 Mn |